Is it time to prospectively match human leukocyte antigen proteins for lung transplantation?
Neuringer
Isabel P
IP
Division of Pulmonary and Critical Care Medicine, University of North Carolina, Chapel Hill, NC, USA. neuringr@med.unc.edu
Aris
Robert M
RM
D016026:Bone Marrow Transplantation / Q000276:immunology; D006085:Graft Survival / Q000276:immunology / Q000502:physiology*; D006680:HLA Antigens / Q000235:genetics / Q000276:immunology*; D015234:HLA-A Antigens / Q000235:genetics / Q000276:immunology; D006684:HLA-DR Antigens / Q000235:genetics / Q000276:immunology; D059951:HLA-G Antigens; D015395:Histocompatibility Antigens Class I / Q000235:genetics / Q000276:immunology; D006650:Histocompatibility Testing / Q000379:methods*; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology; D016031:Liver Transplantation / Q000276:immunology; D016040:Lung Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D015996:Survival Rate; D014184:Transplantation, Homologous / Q000276:immunology
D006680:HLA Antigens; D015234:HLA-A Antigens; D006684:HLA-DR Antigens; D059951:HLA-G Antigens; D015395:Histocompatibility Antigens Class I